Directorate Change

RNS Number : 9889L
Reckitt Benckiser Group PLC
02 January 2019
 

 

 

 

2 January 2019

 

 

 

RECKITT BENCKISER GROUP PLC

('RB' or 'the Company')

 

 

As announced on 13 December 2018, André Lacroix stepped down from the Board of RB and retired as a Non-executive Director of the Company with effect from 31 December 2018.  

 

As required by section 430 (2B) of the Companies Act 2006, it is confirmed that André has not and will not receive any loss of office payments, nor will he be paid any further remuneration other than that accrued up to his date of leaving.

 

The Company's Remuneration Report for the year ending 31 December 2018 will include details of the fees paid to André during the period from 1 January 2018 to 31 December 2018.

 

Contact:

Rupert Bondy

Company Secretary

Reckitt Benckiser Group plc

01753 217800

 

103-105 Bath Road, Slough SL1 3UH

Registered in England and Wales, No. 6270876 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

About RB:

RB is the global leading consumer health, hygiene and home company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries.  From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives.

RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's unique culture is at the heart of its success.  Its drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 employees worldwide. 

For more information visit www.rb.com 

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUBGGUPBGCP
UK 100

Latest directors dealings